| 靶点: |
human muscarinic M1 (hM1), M2 (hM2) and M3 (hM3) receptors |
| 体内研究: |
CHF5407 (0.1, 0.3, 1 nmol/kg; intratracheally; 100 ul; sigle dose) exerted a dose-dependent and potent inhibition of ACh-induced (20 g/kg; i.v.) bronchospasm, with an ED50 value of 0.15 nmol/kg in guinea pigs (450-550 g). |
| 参考文献: |
1. G Villetti, et al. Bronchodilator activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a potent, long-acting, and selective muscarinic M3 rec |
| 保存条件: |
-20℃ |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.63 ml |
8.15 ml |
16.301 ml |
| 5 mM |
0.326 ml |
1.63 ml |
3.26 ml |
| 10 mM |
0.163 ml |
0.815 ml |
1.63 ml |
| 50 mM |
0.033 ml |
0.163 ml |
0.326 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |